Badshah et al. [41] showed that Osmotin could prevent lipopolysaccharide-induced apoptotic neurodegeneration by down-regulating PARP-1 and Caspase 3, thus improving neuroinflammation-associated memory impairment. The gene discussed is CASP3; the disease is memory impairment.